Results 81 to 90 of about 14,967 (152)

Ticagrelor-induced sinus pause: an adenosine-driven side effect. [PDF]

BMJ Case Rep
Fanning JK, Barnes AAB, Betley F, Sondhi S.   +3 more
europepmc   +1 more source

CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study. [PDF]

Front Pharmacol
Haidong S, Min D, Hong Y, Jing Y.
europepmc   +1 more source

Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]

Open Heart
Zheng L, Ren Z, Shi Y, Zou J, Hao C, Li Y, Sun L, Wang D, Liu H, Liang S, Zhu B, Li C.   +11 more
europepmc   +1 more source

Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]

CMAJ
Zhao J, Tian X, Yang X, Xu Q, Xia X, Zhang Y, Xie X, Bath PM, Jing J, Wang Y, Meng X, Wang A.   +11 more
europepmc   +1 more source

Comparative Efficacy of Ticagrelor and Clopidogrel in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging-Based Pilot Study. [PDF]

Acta Cardiol Sin
Wang WT, Lee CY, Huang SS, Huang PH, Hsu PF, Leu HB, Lu TM, Chiou SH, Wang CT, Wu TC.   +9 more
europepmc   +1 more source

Comparison of efficacy and safety between TIcagrelor and clopidogrel in Chinese patients with acute coronary syndrome (COSTIC study). [PDF]

Int J Cardiol Heart Vasc
Huang M, Sun Y, Li K, Yu T, Zhao H, Tao M, Song X, Wang L, Xu X, Chen Y, Cui G, Ding H, Yan J, Jiang J, Zeng H, Wang Y, Shen X, Wang H, Wang DW.   +18 more
europepmc   +1 more source

"Reconsidering CYP3A4/5 Genotyping for Ticagrelor Safety: Critical Appraisal of a Narrow Genetic Framework". [PDF]

Clin Cardiol
Tahir I, Shahbaz H.
europepmc   +1 more source

Unveiling the Hidden Risk: Ticagrelor-Induced Bradyarrhythmias and Conduction Complications in ACS Patients-Case Series. [PDF]

J Cardiovasc Dev Dis
Gorzynska-Schulz A, Stencelewski D, Daniłowicz-Szymanowicz L, Lica-Gorzynska M, Firkowska A, Wabich E.   +5 more
europepmc   +1 more source

Is Ticagrelor-Related Dyspnea a Liability or a Biomarker of Response? [PDF]

Clin Cardiol
Birgün A, Sarıhan A, Kalçık M.
europepmc   +1 more source

Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack. [PDF]

Stroke
Lin J, Zhou H, Wang Y, Jin A, Li S, Zhang L, Meng X, Xie X, Jing J, Jiang Y, Wang Y, Zhao X, Li H, Li Z, Wang Y, CHANCE-2 Investigators.   +15 more
europepmc   +1 more source